RB
RBOT.US Vicarious Surgical Inc.
- Market cap
- USD 21.4K
- P/E
- -
- P/B
- 0.01x
- ROE
- -821.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is RBOT.US undervalued?
Graham numberThe Graham number of Vicarious Surgical Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Vicarious Surgical Inc. fundamental analysis
No fundamental analysis for Vicarious Surgical Inc. yet.
Vicarious Surgical Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts.
Full company profileVicarious Surgical Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Vicarious Surgical Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | - | - | -316K | -1.94M | -1.85M | -2.11M | -1.43M | -732K |
| Operating Income | -9.78M | -13.0M | -38.2M | -80.1M | -80.7M | -66.6M | -51.0M | -30.0M |
| EBITDA | -9.68M | -12.8M | -34.8M | 6.47M | -69.2M | -61.1M | -48.8M | -28.6M |
| Net Income | -9.31M | -12.9M | -35.2M | 5.16M | -71.1M | -63.2M | -50.2M | -29.3M |
| EPS | -1.70 | -3.76 | -11 | 1.21 | -15 | -11 | -8.45 | -4.38 |
| Balance Sheet | ||||||||
| Total Assets | 16.4M | 17.8M | 182M | 140M | 120M | 67.7M | 19.6M | 12.6M |
| Total Liabilities | 733K | 935K | 98.6M | 29.2M | 21.9M | 21.0M | 9.74M | 9.02M |
| Shareholders' Equity | 15.6M | 16.9M | 83.1M | 111M | 98.0M | 46.7M | 9.84M | 3.57M |
| Cash & Short-term Investments | 15.5M | 16.9M | 174M | 116M | 98.2M | 49.1M | 9.79M | 3.68M |
| Total Debt | 158K | 110K | 1.34M | 15.7M | 14.8M | 13.8M | 7.79M | 7.20M |
| Cash Flow | ||||||||
| Operating Cash Flow | -8.71M | -12.0M | -33.3M | -61.2M | -62.3M | -50.0M | -45.1M | -25.3M |
| Capital Expenditure | 246K | 120K | 1.29M | 5.35M | 1.67M | 180K | 132K | 36.0K |
| Free Cash Flow | -8.96M | -12.2M | -34.6M | -66.6M | -64.0M | -50.1M | -45.2M | -25.3M |
| Ratios | ||||||||
| ROE | -59.6% | -76.4% | -42.4% | 4.6% | -72.5% | -135.4% | -509.9% | -821.2% |
| ROA | -56.9% | -72.4% | -19.4% | 3.7% | -59.3% | -93.4% | -256.3% | -232.9% |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.14x | 0.15x | 0.30x | 0.79x | 2.02x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Debt to Equity
- Total debt divided by shareholders' equity.
Vicarious Surgical Inc. dividends
Vicarious Surgical Inc. has not paid dividends in the last 7 fiscal years.
Last stock split: 1:30 on Jun 13, 2024.
Who owns Vicarious Surgical Inc.
- Insiders 14.84%
- Institutions 14.94%
- Public & others 70.22%
- Shares outstanding 6.48M
- Free float 4.16M
Top funds holding RBOT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Arrow Opportunities Alternative Series F | 2.25K | 0.03% | 0.00% | Oct 2026 |
| Arrow Long/Short Alt Fd F | 147.00 | 0.00% | 0.00% | Oct 2026 |
Top institutions holding RBOT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| K5 Global Advisor LLC | 720.00 | 0.01% | 0.00% | Jun 2026 |
| SignatureFD, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Sound Income Strategies | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Hughes Financial Services, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Aspex Management (HK) Ltd | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Forum Finance Group S.A. | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Federation des caisses Desjardins du Quebec | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Rockefeller Capital Management L.P. | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Daytona Street Capital LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
Vicarious Surgical Inc. company profile
- Company name
- Vicarious Surgical Inc.
- Ticker
- RBOT.US
- Exchange
- USA Stocks
- Listed since
- Sep 4, 2020
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 48
- Fiscal year end
- December
- Address
- 78 Fourth Avenue, Waltham, MA, United States, 02451
- Phone
- 617 868 1700
- Website
- vicarioussurgical.com
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts.
Vicarious Surgical Inc. management
4- Mr. Stephen FromCEO & Director · born 1963
- Mr. Adam David SachsCo-Founder, President & Director · born 1992
- Mr. Sammy KhalifaCo-founder, CTO & Director · born 1991
- Mr. Barry Stuart Greene F.A.C.S., M.D.Co-founder & Chief Medical Officer